Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Todos Medical Ltd.
  6. News
  7. Summary
    TOMDF   IL0011392375

TODOS MEDICAL LTD.

(TOMDF)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

TODOS MEDICAL LTD. : Other Events (form 8-K)

05/04/2021 | 03:09pm EDT

Item 8.01 Other Events.

On May 4, 2021, Todos Medical Ltd. (the "Company") announced that the US Food & Drug Administration granted the Company a new Certificate of Free Sale for a second dosing regimen for Tollovid™ as a dietary supplement. Under the new Certificate of Free Sale, the Company is authorized to market Tollovid with a dosing regimen of 60 pills over a five-day period, equivalent to 12 pills per day.

© Edgar Online, source Glimpses

All news about TODOS MEDICAL LTD.
06/22TODOS MEDICALá : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
05/04TODOS MEDICAL LTD.á : Other Events (form 8-K)
AQ
05/04TODOS MEDICALá : Receives FDA Certificate of Free Sale for New 5-Day Tollovid Do..
AQ
04/30TODOS MEDICAL LTD.á : Entry into a Material Definitive Agreement, Creation of a ..
AQ
04/23TODOS MEDICAL LTD.á : Entry into a Material Definitive Agreement, Completion of ..
AQ
04/22Todos Medical Acquires Provista Diagnostics and Its Proprietary Videssa Breas..
GL
04/21TODOS MEDICALá : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
04/19Todos Medical Launches Phase 2 Clinical Trial of Its Antiviral 3CL Protease I..
GL
04/14TODOS MEDICAL LTD.á : Entry into a Material Definitive Agreement, Creation of a ..
AQ
04/08Todos Medical Receives Notice of Allowance from European Patent Office for Pa..
GL
More news
Financials (USD)
Sales 2020 5,21  - -
Net income 2020 -29,8 M - -
Net Debt 2020 10,5 M - -
P/E ratio 2020 -0,65x
Yield 2020 -
Capitalization 19,8 M 19,8 M -
EV / Sales 2019 -
EV / Sales 2020 7 726 750x
Nbr of Employees 7
Free-Float 67,4%
Chart TODOS MEDICAL LTD.
Duration : Period :
Todos Medical Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
NameTitle
Gerald E. Commissiong President, Chief Executive Officer & Director
Daniel Hirsch Chief Financial Officer & Director
Herman Weiss Chairman
Elise Brownell Vice President-Research & Development
Jorge Leon Chief Medical & Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
TODOS MEDICAL LTD.-54.00%20
EXACT SCIENCES CORPORATION-1.15%22 468
GUARDANT HEALTH, INC.-0.96%12 907
BGI GENOMICS CO., LTD.-9.40%7 483
INVITAE CORPORATION-19.13%6 756
ADAPTIVE BIOTECHNOLOGIES CORPORATION-30.73%5 747